Alfuzozin

Alfuzozin – the selection blocker _{of alfa1-adrenoceptors} (is preferential in a zone of an urethra, predyostatelny gland and a triangle uric пузы­ря) reducing pressure in an urethra, reducing resistance to urine current, facilitating an urination and eliminating a dysuria.

Form of release and structure

• Tablets of the prolonged action: a round form, ploskotsilindrichesky, color, white or white with a yellowish shade, with a facet (on 10 pieces in blister strip packagings, in a pack of cardboard 1, 3, 5 or 6 packagings; on 14 pieces in blister strip packagings, in a pack cardboard 1, 2 or 4 packagings);
• Tablets with controlled release, coated: round form, biconvex, color, light yellow with a weak korichnevayoty shade; on a break – white or almost бело­го colors (on 10 pieces in blister strip packagings, in a pack of cardboard 6 packagings).

Active agent – an alfuzozina a hydrochloride:

• 1 tablet of the prolonged action – 5 or 10 mg;
• 1 tablet with controlled release – 5 mg.

Auxiliary components of tablets of the prolonged action: коллидон SR (polyvinyl acetate, povidone, sodium lauryl sulfate, silicon dioxide), magnesium stearate, lactoses monohydrate, silicon dioxide colloid.

Additional substances of tablets with controlled release: magnesium stearate for pharmaceutical industry, povidone sredneyomolekulyarny (polyvinylpirrolidone middlemolecular), a hypro rod (hydroxypropyl cellulose), calcium of a gidroyofosfat a dihydrate (calcium phosphate disubstituted 2-water), cellulose microcrystallic, titanium dioxide, a gipromelloz (gidroksipropilmetiltsellyuloz), talc, the castor oil hydrogenated dye ferrous oxide yellow.

Indications to use

Alfuzozin – drug for treatment of the functional disturbances of an urination caused by a benign hyperplasia of a prostate.

Contraindications

• Heavy insufficiency of function of a liver;
• Orthostatic hypotension (including in the anamnesis);
• Simultaneous use of other alpha adrenoblockers;
• Hypersensitivity to drug components.

Alfuzozin is not applied to treatment of women.

With care:

• Chronic renal failure;
• Coronary heart disease;
• The age is more senior than 75 years;
• Simultaneous use of hypotensive drugs.

Route of administration and dosage

Alfuzozin it is necessary to accept inside, swallowing of tablets entirely and washing down with enough water.

The recommended daily dose makes 10 mg – on 1 tablet of 10 mg of 1 times a day or on 1 tablet of 5 mg 2 times a day, in the morning and in the evening, at the same time it is necessary to begin treatment with evening reception.

To elderly people and patients who receive the accompanying hypotensive therapy appoint 5 mg of 1 times a day (in the evening). If necessary increase in a dose up to 10 mg is possible.

Side effects

• From the alimentary system: nausea, dryness in a mouth, diarrhea, pain in epigastriums;
• From cardiovascular system: orthostatic gipotenyoziya, tachycardia; patients with coronary heart disease have an aggravation of symptoms of a stenokaryodiya;
• From a nervous system: dizziness, headache, sonliyovost, weakness, asthenic syndrome;
• Allergic reactions: itch, skin rashes;
• Others: dermahemia, sonitus, hypostases.

Special instructions

In certain cases, especially at the patients receiving hypotensive drugs within several hours after Alfuzozin's reception postural hypotension, with symptoms (sweating, fatigue and dizziness) and without them can develop. Such persons need to remain in a prone position before improvement of a state. These phenomena are more often than a vremenna, arise at the beginning of therapy and, as a rule, are not a reason for drug withdrawal.

At combined use of antihypertensives, especially blockers of calcium channels, it is necessary to adjust their doses since the lowering of arterial pressure is possible, up to development of a collapse.

Patients with coronary insufficiency have to accept Alfuzozin at the same time with specific treatment of coronary insufficiency. If stenocardia is returned or worsens, Alfuzozin it is necessary to cancel.

There are no data on a negative impact of drug on the speed of reactions and ability to concentration of attention. However in an initiation of treatment there can be an adynamy and dizziness therefore patients should be careful when driving and performing potentially dangerous types of works.

Medicinal interaction

Alfuzozin it is impossible to apply along with other _{alfa1-adrenoblockers} as there is strengthening of hypotensive effect owing to what the risk of development of heavy postural hypotension increases.

Drug strengthens effect of anti-hypertensive means, including blockers of slow calcium channels (the additive action is noted) and the general anesthetics (instability of arterial pressure is possible).

At simultaneous use of inhibitors of the CYP3A4 system (an itrakonazol, a ketokonazol, a ritonavir) concentration of an alfuzozin in blood increases.

Terms and storage conditions

To store at a temperature up to 25 ºС in the unavailable to children, protected from light and dry place.

Period of validity – 2 years.